Pregabalin for the treatment of generalized anxiety disorder: an update
David S Baldwin,1–3 Khalil Ajel,3 Vasilios G Masdrakis,4 Magda Nowak,1 Rizwan Rafiq31Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK; 2Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Afr...
Guardado en:
Autores principales: | Baldwin DS, Ajel K, Masdrakis VG, Nowak M, Rafiq R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69dadd853ece42a99a4e5f92f6a1d795 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Duloxetine in the treatment of generalized anxiety disorder
por: Trevor R Norman, et al.
Publicado: (2009) -
Duloxetine for the treatment of generalized anxiety disorder: a review
por: Ahsan Y Khan, et al.
Publicado: (2008) -
New treatment options in the management of fibromyalgia: role of pregabalin
por: Grazyna Zareba
Publicado: (2008) -
Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan MN, et al.
Publicado: (2015) -
Pregabalin for the management of partial epilepsy
por: Philippe Ryvlin, et al.
Publicado: (2008)